Article

A cognitive behavioral intervention for symptom management in patients with advanced cancer.

School of Nursing, University of Pittsburgh, Pittsburgh, PA, USA.
Oncology Nursing Forum (Impact Factor: 1.91). 12/2005; 32(6):1190-8. DOI: 10.1188/05.ONF.1190-1198
Source: PubMed

ABSTRACT To evaluate the effectiveness of a cognitive behavioral intervention in decreasing symptom severity in patients with advanced cancer undergoing chemotherapy.
Prospective, randomized clinical trial based on cognitive behavioral theory.
Six urban cancer centers in the midwestern United States.
124 patients 21 years of age or older were recruited and randomized to receive conventional care or conventional care and an intervention. Participants were newly diagnosed with stage III, stage IV, or recurrent cancer (solid tumor or non-Hodgkin lymphoma), undergoing chemotherapy, cognitively intact, and able to read and speak English.
Data were gathered via telephone interviews at baseline and 10 and 20 weeks after randomization. Nurses with experience in oncology delivered a five-contact, eight-week intervention aimed at teaching patients problem-solving techniques to affect symptom severity.
Gender, site of cancer, age, symptom severity and depressive symptoms at baseline, group (i.e., experimental versus control), and total symptom severity.
Patients in the experimental group and those with lower symptom severity at baseline had significantly lower symptom severity at 10 and 20 weeks; the experimental difference at 20 weeks occurred primarily in those 60 years of age and younger. Depressive symptoms at baseline predicted symptom severity at 20 weeks; however, age, gender, and site of cancer did not affect symptom severity at either time point.
A cognitive behavioral intervention to teach problem-solving skills can be effective for patient symptom self-management during and following an intervention.
Problem-solving strategies should be included in educational programs for patients with advanced cancer, particularly those 60 years of age and younger.

0 Bookmarks
 · 
114 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Caregiving burden affects the lives of family members providing care to patients with advanced cancer, with a host of factors possibly contributing to this. The aim of this study was to explore the effects of patient and caregiver variables on the perceptions of burden in families caring for a loved one living with advanced cancer in Greece. A convenience sample of 100 pairs of patients receiving palliative radiotherapy for advanced cancer and their respective primary family caregivers were consecutively recruited at one radiotherapy centre. Patients and caregivers completed a set of questionnaires during face-to-face interviews. Correlational and multiple regression analyses were performed to identify potential predictors of caregiving burden. Caregiving burden was linked to both patient (gender, age, past surgery or chemotherapy treatment, depression and impact of cancer-related symptoms) and caregiver variables (gender, family status, education, place of residence, previous experience of care, employment status, difficulty of caregiving, anxiety and depression). In multiple regression analyses, caregiving burden was significantly predicted by caregivers' depressed mood, perceived difficulty of caregiving, family status, employment status, as well as by patients' past surgery, in a model that explained 49% of the total variance. Greek family caregivers reporting greater depressive mood and difficulty with caregiving tasks, those married, those not employed, and those who cared for patients who had not undergone surgery were found at greater distress and disadvantage. Systematic assessment and intervention strategies are required to identify these vulnerable carers and help them cope when sharing in patient's cancer experience. Copyright © 2014 Elsevier Ltd. All rights reserved.
    European journal of oncology nursing: the official journal of European Oncology Nursing Society 10/2014; DOI:10.1016/j.ejon.2014.06.009 · 1.13 Impact Factor
  • Journal of Cancer Therapy 01/2011; 02(02):105-109. DOI:10.4236/jct.2011.22012
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Although sleep is vital to all human functioning and poor sleep is a known problem in cancer, it is unclear whether the overall prevalence of the various types of sleep disorders in cancer is known. The purpose of this systematic literature review was to evaluate if the prevalence of sleep disorders could be ascertained from the current body of literature regarding sleep in cancer. This was a critical and systematic review of peer-reviewed, English-language, original articles published from 1980 through 15 October 2013, identified using electronic search engines, a set of key words, and prespecified inclusion and exclusion criteria. Information from 254 full-text, English-language articles was abstracted onto a paper checklist by one reviewer, with a second reviewer randomly verifying 50% (k = 99%). All abstracted data were entered into an electronic database, verified for accuracy, and analyzed using descriptive statistics and frequencies in SPSS (v.20) (North Castle, NY). Studies of sleep and cancer focus on specific types of symptoms of poor sleep, and there are no published prevalence studies that focus on underlying sleep disorders. Challenging the current paradigm of the way sleep is studied in cancer could produce better clinical screening tools for use in oncology clinics leading to better triaging of patients with sleep complaints to sleep specialists, and overall improvement in sleep quality.
    Cancer Medicine 11/2014; 4(2). DOI:10.1002/cam4.356

Preview

Download
1 Download
Available from